206
Views
13
CrossRef citations to date
0
Altmetric
Review

Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations

, , , , &
Pages 365-375 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nidhi Chauhan, Sukirti Tiwari, Tessy Iype & Utkarsh Jain. (2017) An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Expert Review of Vaccines 16:5, pages 491-502.
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now

Articles from other publishers (11)

Felicity C. Stark, Bassel Akache, Lise Deschatelets, Anh Tran, Matthew Stuible, Yves Durocher, Michael J. McCluskie, Gerard Agbayani, Renu Dudani, Blair A. Harrison, Tyler M. Renner, Shawn R. Makinen, Jegarubee Bavananthasivam, Diana Duque, Martin Gagne, Joseph Zimmermann, C. David Zarley, Terrence R. Cochrane & Martin Handfield. (2022) Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters. Scientific Reports 12:1.
Crossref
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, Kan Kaneko, Krutika K. Sawant, Nitesh K. Kunda & Imran Y. Saleem. (2021) An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 13:4, pages 455.
Crossref
Nozad Rashid Hussein, Huner Kamal Omer, Abdelbary M.A. Elhissi & Waqar Ahmed. 2020. Advances in Medical and Surgical Engineering. Advances in Medical and Surgical Engineering 279 311 .
Cynthia Calzas & Christophe Chevalier. (2019) Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Frontiers in Immunology 10.
Crossref
Susana Martiñón, Angel Cisneros, Sergio Villicaña, Ricardo Hernández-Miramontes, Edgar Mixcoha & Psyché Calderón-Vargas. (2019) Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants. Journal of Immunology Research 2019, pages 1-9.
Crossref
Weiping Cao, Jin Hyang Kim, Adrian J. Reber, Mary Hoelscher, Jessica A. Belser, Xiuhua Lu, Jacqueline M. Katz, Shivaprakash Gangappa, Martin Plante, David S. Burt & Suryaprakash Sambhara. (2017) Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice. Vaccine 35:25, pages 3318-3325.
Crossref
Rob Lambkin-Williams, Colin Gelder, Richard Broughton, Corey P. Mallett, Anthony S. Gilbert, Alex Mann, David He, John S. Oxford & David Burt. (2016) An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection. PLOS ONE 11:12, pages e0163089.
Crossref
Shin-ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata & Hideki Hasegawa. (2016) Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?. Japanese Journal of Infectious Diseases 69:3, pages 165-179.
Crossref
Anthony E. Fiore, Carolyn B. Bridges, Jacqueline M. Katz & Nancy J. Cox. 2013. Vaccines. Vaccines 257 293 .
Bethan Hughes, Frederick Hayden, Yuri Perikov, Joachim Hombach & John S. Tam. (2012) Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16–17 November 2011. Vaccine 30:47, pages 6612-6622.
Crossref
Nils Lycke. (2012) Recent progress in mucosal vaccine development: potential and limitations. Nature Reviews Immunology 12:8, pages 592-605.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.